Repisaludmetadata only
Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.
relecov, multicentre study, rsv, genomic and antigenic surveillance, nirsevimab, antibodies, monoclonal, humanized, antibodies, viral, antigens, viral
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 672217
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.